Exicure Inc
2H0
Company Profile
Business description
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Contact
400 Seaport Court
Suite 102
Redwood CityCA94063
USAT: +1 847 673-1700
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
7
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,502.30 | 8.40 | -0.10% |
| CAC 40 | 7,873.83 | 23.73 | 0.30% |
| DAX 40 | 23,638.56 | 72.02 | 0.31% |
| Dow JONES (US) | 42,140.43 | 269.67 | -0.64% |
| FTSE 100 | 8,602.92 | 2.06 | -0.02% |
| HKSE | 23,316.45 | 208.18 | 0.90% |
| NASDAQ | 19,010.09 | 301.74 | 1.61% |
| Nikkei 225 | 37,957.45 | 225.81 | -0.59% |
| NZX 50 Index | 12,807.96 | 21.22 | 0.17% |
| S&P 500 | 5,886.55 | 42.36 | 0.72% |
| S&P/ASX 200 | 8,257.00 | 12.00 | -0.15% |
| SSE Composite Index | 3,374.69 | 0.18 | -0.01% |